Pharmacology, Toxicology and Pharmaceutical Science
Diabetes Mellitus
100%
Congestive Heart Failure
86%
Streptozotocin
67%
Daunorubicin
61%
Inflammation
53%
Angiotensin II
48%
Diseases
47%
Congestive Cardiomyopathy
47%
Curcumin
46%
Antioxidant
46%
Experimental Autoimmune Myocarditis
44%
Diabetic Cardiomyopathy
43%
Olmesartan
38%
Cytokine
36%
4 Hydroxynonenal
36%
Nephrotoxicity
34%
Angiotensin Receptor Antagonist
34%
Cardiotoxicity
33%
Receptor
33%
Aldehyde Dehydrogenase Isoenzyme 2
31%
Mitogen Activated Protein Kinase P38
31%
Senescence Accelerated Mouse
30%
Telmisartan
30%
Heart Ventricle Remodeling
29%
Heart Muscle Fibrosis
29%
Cardiovascular Disease
28%
Hyperglycemia
26%
Transgenic Mouse
26%
Protein 14 3 3
26%
Diabetic Nephropathy
24%
Torasemide
23%
Carvedilol
23%
Furosemide
23%
Heart Failure with Preserved Ejection Fraction
23%
Fibrosis
22%
Schizandrin B
20%
Mitogen Activated Protein Kinase
20%
Messenger RNA
19%
Heart Injury
19%
Edaravone
18%
Myocarditis
18%
Endothelial Dysfunction
18%
Colitis
18%
Heart Disease
17%
Kidney Injury
17%
Endothelin 1
17%
Liver Injury
17%
Angiotensin 1 Receptor Antagonist
16%
Pathophysiology
15%
Quercetin
15%
Keyphrases
Endoplasmic Reticulum Stress (ER stress)
32%
Daunorubicin
30%
14-3-3 Protein
30%
Cardiotoxicity
29%
Diabetic Cardiomyopathy
28%
Angiotensin II Type 1 Receptor (AT1R)
24%
Cardiomyocyte Apoptosis
22%
Experimental Autoimmune Myocarditis
21%
Dominant Negative
21%
Mitogen-activated Protein Kinase
20%
Apoptosis
20%
Oxidative Stress
20%
Beneficial Effects
19%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
18%
Dilated Cardiomyopathy
16%
Nephrotoxicity
15%
Carbones
15%
SIRT1 Signaling
15%
Carvedilol
15%
STK35
15%
Curcumin
15%
Olmesartan
15%
MAPK Cascade
15%
Schisandrin B
15%
Cardiac Function
15%
Protein Expression
13%
Cardioprotection
13%
Pressure Overload
12%
Protein Homology
12%
Diabetic
11%
Diabetes
11%
Cardiac Dysfunction
11%
P-AMPK
11%
Angiotensin II (Ang II)
10%
CCAAT/enhancer-binding Protein Homologous Protein
10%
ERK2
10%
EndoMT
10%
Stress-induced
10%
Caspase-12
9%
AMPK Activation
9%
Anthracycline-induced Cardiotoxicity
9%
Antioxidant
9%
Human Disease
8%
Heart Failure
8%
Endothelin-1 (ET-1)
8%
Inflammation
8%
Angiotensin Receptor Blockers
8%
Schisandra chinensis
8%
Inositol-requiring Enzyme 1 (IRE1)
7%
Efferocytosis
7%
Medicine and Dentistry
Congestive Heart Failure
41%
Heart Function
29%
Antioxidant
25%
Programmed Cell Death
24%
Endoplasmic Reticulum Stress
24%
Diabetes Mellitus
24%
Diabetes
23%
Diabetic Cardiomyopathy
23%
Angiotensin II
20%
Mitogen Activated Protein Kinase P38
19%
Edaravone
18%
Oxidative Stress
18%
Diseases
18%
Endothelial Dysfunction
18%
Endothelial Cell
18%
Experimental Autoimmune Myocarditis
17%
Pathophysiology
16%
Nephrotoxicity
15%
Right Ventricle
15%
Liposomal Daunorubicin
15%
Heart Right Ventricle Failure
15%
Olmesartan
15%
Aldehyde Dehydrogenase Isoenzyme 2
15%
Gene Therapy
15%
Fibrosis
14%
Heart Disease
12%
Hyperglycemia
12%
Mediator
10%
extracellular signal regulated kinase
9%
Cardiovascular System
8%
Kampo
8%
Heart Injury
8%
Kidney Injury
8%
Cardiovascular Disease
8%
Torasemide
7%
Randomized Controlled Trial
7%
Inflammatory Bowel Disease
7%
Neurologic Disease
7%
Myocarditis
7%
Progeria
7%
microRNA
7%
Regeneration
7%
Histamine H2 Receptor
7%
Mast Cell
7%
Furosemide
7%
Cell Signaling Pathway
7%
Doxorubicin
7%
Macrophage Polarization
7%
Angiotensin Receptor Antagonist
7%
Empagliflozin
7%